Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.KV Pharmaceutical suspends production
Additionally, the company will conduct a voluntary recall of most of its products. The scope and depth of the recall are currently under discussion with the FDA. These
Additionally, the company will conduct a voluntary recall of most of its products. The scope and depth of the recall are currently under discussion with the FDA. These
Irinotecan is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy. This product is available for
According to the company, the Talent abdominal stent graft expands the applicability of endovascular aneurysm repair, enabling more patients to benefit from a minimally invasive alternative to open
The FiberNet embolic protection system (EPS), which received the FDA clearance in November 2008, is indicated for the treatment of patients receiving endovascular intervention for carotid artery disease.
The complex human EGF receptor (HER) family of receptors and growth factor ligands is dysregulated in about half of all solid cancers. Receptor BioLogix’s pan-HER ligand traps are
Under the terms of the agreement, CPC Scientific will offer Sigma-Aldrich’s PEPscreen custom peptide libraries to life science researchers and pharmaceutical companies in North America. Sigma-Aldrich has developed
These trials are the first step toward the FDA clinical trials to test the efficacy of using International Stem Cell Corporation (ISCO) cells to improve healing after corneal
The commission has approved an agreement containing consent order that Getinge and Datascope entered into with the Federal Trade Commission (FTC) staff on January 15, 2009 and has
Pursuant to the terms of the agreement, Laiyang will purchase the majority of the assets owned by Hongrui, including all tangible assets, including without limitation, all manufacturing and
Mr Casdin is founder of Casdin Advisors where he serves as a strategic advisor to the life sciences industry. Mr Casdin holds an MBA from Columbia Business School,